Literature DB >> 4452945

Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.

.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4452945

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  7 in total

1.  Clinically inactive thyroid U.S.P. A preliminary report.

Authors:  B CATZ; E GINSBURG; S SALENGER
Journal:  N Engl J Med       Date:  1962-01-18       Impact factor: 91.245

2.  Determination of physiologic availability of commercial phenylbutazone preparations.

Authors:  W L Chiou
Journal:  J Clin Pharmacol New Drugs       Date:  1972-07

3.  Equivalence lack in digoxin plasma levels.

Authors:  J G Wagner; M Christensen; E Sakmar; D Blair; J D Yates; P W Willis; A J Sedman; R G Stoll
Journal:  JAMA       Date:  1973-04-09       Impact factor: 56.272

4.  Variation in biologic availability of digoxin from four preparations.

Authors:  J Lindenbaum; M H Mellow; M O Blackstone; V P Butler
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

5.  An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.

Authors:  A J Glazko; A W Kinkel; W C Alegnani; E L Holmes
Journal:  Clin Pharmacol Ther       Date:  1968 Jul-Aug       Impact factor: 6.875

6.  The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.

Authors:  R J Withey; H Feng; D Cook; G R Van Petten; H F Lettau
Journal:  J Clin Pharmacol New Drugs       Date:  1971 May-Jun

7.  Assessment of the biologic availability of tetracycline products in man.

Authors:  W H Barr; L M Gerbracht; K Letcher; M Plaut; N Strahl
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875
  7 in total
  3 in total

1.  A history of biopharmaceutics in the Food and Drug Administration 1968-1993.

Authors:  Jerome Philip Skelly
Journal:  AAPS J       Date:  2009-11-20       Impact factor: 4.009

2.  Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures.

Authors:  Ingeborg Walter-Sack; Christof Clanget; Reinhard Ding; Christoph Goeggelmann; Vera Hinke; Matthias Lang; Johannes Pfeilschifter; Yorki Tayrouz; Karl Wegscheider
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 3.  Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy.

Authors:  K S Amidon; P Langguth; H Lennernäs; L Yu; G L Amidon
Journal:  Clin Pharmacol Ther       Date:  2011-07-20       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.